All Episodes
Psychedelics Today — 779 episodes · page 5 of 8
PT290 – Kylea Taylor, M.S., LMFT – Vital Psychedelic Conversations
PT289 – Payton Nyquvest – Shifting the Mindset on Pain, Psychedelics, and Accessibility
PT283 – Greg McKee – Psychedelics for Nociplastic Pain
PT281 – Oliver Grundmann, Ph.D. – A Thorough Exploration of Kratom
PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations
PT287 – Josh Hardman – Psychedelic Stocks, Data Privacy, and Drug Development
PT286 – Joe Tafur, MD – Vital Psychedelic Conversations
PT285 – Andrew Penn, NP – The Need for Nurses in Psychedelics, The Placebo Effect, and Appreciating the Subtle
PT284 – Jonathan Sabbagh – Ketamine-Assisted Psychotherapy and Collaborative Care
PT282 – Rabbi Zac Kamenetz & The Rev. Hunt Priest – Judaism, Christianity, and Embracing Psychedelics
PT280 – Danny Peterson – Psychedelics, Religion, and Freedom
PT279 – Joe Zap & Kevin W – Cannabis Acceptance, Conspiratorial Thinking, and Psychedelic Podcasting
PTSF90 – Colorado's Natural Medicine Healing Act and Guidelines for Emergency Ketamine Administration
PT278 – Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara – A Table of Our Own
PTSF89 – A Macro Dive Into Microdosing
PT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative Financing Vine
PTSF88 – Dr. Ben Sessa of Awakn Life Sciences + Josh Bartch of Mydecine Innovations Group
PT276 – Micah Haskell-Hoehl – Healing, Equity, and Federal Policy
PTSF87 – Ketamine, Addiction, and Mysticism + Kelsey Ramsden of MINDCURE
PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your Symphony of Selves
PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest of Numinus
PT274 – Juan Pablo Cappello – Nue Life: Using Digital Phenotyping to Personalize Healthcare
PTSF85 – Ahmad Doroudian, Ph.D. of BetterLife Pharma and Dr. Abid Nazeer of Wesana Health
PT273 – Erica Rex – Clinical Trials and Spontaneous Mystical Experiences
PT272 – Veterans Day 2021
PTSF84 – A Brief Check-in From Wonderland
PT271 – Jeremy Narby, Ph.D. – Anthropology, Ayahuasca, and Plant Teachers
PT270 – Dr. Rachel Yehuda – Research Trials and The Future of Psychedelic Neuroscience
PT269 – Adam Strauss – Comedy, OCD, and The Mushroom Cure
PTSF83 – Abuse in Psychedelics: Complicity and Groupthink
PT268 – Hamilton Morris – PCP, 5-MeO-DMT, and The Synthesis of New Psychedelics
PTSF82 – Wonderland Miami, with Patrick Moher of Microdose
PT267 – Rebecca Kronman, LCSW – Pregnancy, Parenthood, and Psychedelics
PTSF81 – Somatics, Reframing Trauma, and the 7 Lens Approach, with Liam Farquhar
PT266 – Jerry B. Brown, Ph.D. – Psychedelics: Past, Present, and Future
PTSF80 – Decriminalization in Seattle, San Pedro, and The Dark Web
PT265 – Jessica Cadoch, MA – Cooperation, Drug Exceptionalism, and 12-step Programs
PTSF79 - Psychedelic Facilitator Abuse and Space Holding Ethics with Dr. Ido Cohen
PT264 – Gibrán Rivera – Group Process, Self-sovereignty, and Rethinking Masculinity
PTSF78 – Navigating the Vast Psychedelic Space: Where Do You Fit In?
PT263 – Michelle Janikian – 920: The Magic Mushroom Holiday
PTSF77 – Progress and Context, with Jesse Gould of Heroic Hearts Project
PT262 – Carlene MacMillan, M.D. – Set, Setting, and Systems: Adding Insurance to the Conversation
PTSF76 – Spiritual Emergence and Healing
PT261 – Dr. Tiago Reis Marques – Ketamine, New Drugs, and the Repurposing of Current Drugs
PTSF75 – Possession Limits, Religion, and Scalability
PT260 – Benjamin Mudge – Ayahuasca and Bipolar: Pathways to a Protocol
PTSF74 – A Response: Decriminalize Nature, SB-519, and MAPS
PT259 – Dr. Devon Christie and Will Siu, MD, DPhil – The Mind-Body Connection, MDMA, and Chronic Pain
PTSF73 – Origin Stories, Complexity, and Transpersonal Psychology
PT258 – Manesh Girn – Psychedelics and the Brain: Neuroplasticity and Creativity
PTSF72 – Breaking Down SB-519, with MAPS' Ismail L. Ali
PT257 – Robin Divine – Black People Trip
PTSF71 – Sexual Ethics in Psychedelics and Mistrust of Big Pharma
PT256 – Matthew D. Segall, Ph.D. – Consciousness, Capitalism, and Philosophy
PTSF70 – Depth Psychology, The Reach of the DEA, and Progress in the Northeast
PT255 – Jasmine Virdi – Conservation, Covid, and Neurodivergence
PTSF69 – Well-being and Working With Weirdness
PT254 – Daniel Moler – San Pedro, Comic Books, and Finding Your Flow
PTSF68 – Neuroplasticity, Michael Pollan, and DMT, with Manesh Girn
PT253 – Sean Hinton Ph.D. – Culture, Research Limitations, and Non-Medical Paths Forward
PTSF67 – Psilocybin, Power, and Patents
PT252 – Joel Lambert – Ibogaine, 5-MeO-DMT, and The Warrior Tradition
PTSF66 – Philosophical Critiques, Legalization Updates, and Inclusive Research
PT251 – Kristina & Jonas of the Psychedelic Literacy Fund – Celebrating Stan Grof
PT250 – Matt – New Frameworks For Schizophrenia, Dissociation, and Suicidal Ideation
PTSF65 - Navigating Psychedelics for Clinicians and Therapists, and Nitrous Oxide for Depression
PT249 – Hadas Alterman, Serena Wu, and Adriana Kertzer of Plant Medicine Law Group
PTSF64 - The First Woman to Take Acid, The Drug Policy Reform Act, and Indigenous Language Extinction
PT248 – Pierre Bouchard – Somatic Therapy, Trauma, and the Nervous System
PTSF63 - The Media and Legalization, Joints for Jabs, and 40,000 Ecstasy Pills
PT247 – Julian Vayne – Magic, Prohibition, and New Models for Legality
PTSF62 - Senate Bill 519, Ketamine, and Psilocybin-producing Cicadas
PT246 - Amber and Marcus Capone of VETS - Foundational Healing and the Brain
PTSF61 – Archetypal Astrology and the Inner Healer, with Renn Butler
PT245 – Robin Carhart-Harris – Psychedelics, Entropy, and Plasticity
PTSF60 – Representation and Access, with Elan Hagens and Rebecca Martinez of Fruiting Bodies Collective
PT244 – Mark Haberstroh – Mushrooms, Retreat Centers, and Safety
PTSF59 – Psychedelics and Bipolar, with Benjamin Mudge
PT243 – Dr. Fernando Espi Forcen and Dr. Franklin King of MGH's Center for the Neuroscience of Psychedelics
PTSF58 - Liberty, The Power of Therapy, and Mushrooms in Maine
PT242 - Gary Laderman - Religion: Sex, Death, and Drugs
PTSF57 - New Compounds, Psychedelic Business, and Neurogenesis
PTSF57 - New Compounds, Psychedelic Business, and Neurogenesis
PT241 - Tyler Chandler and Nick Meyers of "Dosed": Iboga and The Opioid Crisis
PTSF56- Data vs. Spin, with Tim Cools of Psychedelic Experience
PT240 - Ralph Blumenthal - Alien Abductions and The Believer
PTSF55 - Creativity, Group Ceremony, and Astral Projection
PT239 - Richie Ogulnick - Ibogaine, Unicity, and Beneficence
PTSF54 - Theft, Patents, and Ethical Psychedelic Companies
PT238 - Kile Ortigo - Integration and Existential Exploration
PTSF53 - Psychedelics and Creativity, with Laura Dawn
PT237 - Dena Justice - Finding the Frequency of Safety
PTSF52 - Start Low, Go Slow
PT236 - Dr. Carl Hart - Drugs: Honesty, Responsibility, and Logic
PTSF51 - Miracle Cures, Money, and Standing on the Shoulders of Giants
PT235 - The Entheo Society of Washington - Dismantling Power Systems Through Decriminalization
PTSF50 - Microdosing and the Placebo Effect, with Balázs Szigeti and David Erritzoe
PT234 - Christopher Solomon - Salvia as a Therapist
PTSF49 - MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians